- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有71家主力机构披露2025-06-30报告期持股数据，持仓量总计1563.51万股，占流通A股27.99%
- 波段诊断：
-
技术面诊股
诊断结果：6.5技术面打败了46%的股票
技术面评分前10的股票
近期的平均成本为28.02元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为28.02元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"28.02","date":1760433906,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.10.15","stock":"0.39","trade":null,"ind":"1.22"},{"date":"2025.10.14","stock":"-1.80","trade":null,"ind":"-0.62"},{"date":"2025.10.13","stock":"-0.77","trade":null,"ind":"-0.19"},{"date":"2025.10.10","stock":"-0.80","trade":null,"ind":"-0.94"},{"date":"2025.10.09","stock":"0.91","trade":null,"ind":"1.32"},{"date":"2025.09.30","stock":"1.93","trade":null,"ind":"0.52"},{"date":"2025.09.29","stock":"1.15","trade":null,"ind":"0.90"},{"date":"2025.09.26","stock":"-0.54","trade":null,"ind":"-0.65"},{"date":"2025.09.25","stock":"0.18","trade":null,"ind":"-0.01"},{"date":"2025.09.24","stock":"2.77","trade":null,"ind":"0.83"},{"date":"2025.09.23","stock":"-1.13","trade":null,"ind":"-0.18"},{"date":"2025.09.22","stock":"-1.19","trade":null,"ind":"0.22"},{"date":"2025.09.19","stock":"-0.43","trade":null,"ind":"-0.30"},{"date":"2025.09.18","stock":"-1.42","trade":null,"ind":"-1.15"},{"date":"2025.09.17","stock":"-1.16","trade":null,"ind":"0.37"},{"date":"2025.09.16","stock":"0.92","trade":null,"ind":"0.04"},{"date":"2025.09.15","stock":"-0.77","trade":null,"ind":"-0.26"},{"date":"2025.09.12","stock":"-1.96","trade":null,"ind":"-0.12"},{"date":"2025.09.11","stock":"0.28","trade":null,"ind":"1.65"},{"date":"2025.09.10","stock":"-0.34","trade":null,"ind":"0.13"},{"date":"2025.09.09","stock":"-2.94","trade":null,"ind":"-0.51"}]
睿昂基因,上证指数,医疗器械指数
压力支撑
该股压力位为27.77元，支撑位为27.08元。
[{"text":"\u538b\u529b\u4f4d","value":"27.77","date":1760457600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"27.08","date":1760457600,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.8资金面打败了95%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月15日 20:41
| 机构今日流向(万元) | 345.66 | 机构5日流向(万元) | -3101.60 |
| 机构10日流向(万元) | -1554.22 | 机构20日流向(万元) | -11324.90 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加192.87万股，其中基金净增仓4家，主力净增仓51家，有一定的中长期投资价值。
截止2025-06-30，共71家主力机构（基金66家，一般法人5家），持仓量总计1563.51万股，占流通A股27.99%
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 36.76万股
减仓：1家 ，减持 0.04万股
新出现在主力名单中：59家 ，持有166.46万股
从主力名单中消失：8家 ，原持有10.31万股
其中，基金持仓与2024-12-31相比：
增仓：5家 ，增持 36.76万股
减仓：1家 ，减持 0.04万股
新出现在主力名单中：59家 ，持有166.46万股
从主力名单中消失：8家 ，原持有10.31万股
消息面诊股
诊断结果：5.9消息面打败了76%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 睿昂基因：10月14日获融资买入131.99万元
2025-10-15 - 睿昂基因：10月13日获融资买入190.30万元
2025-10-14 - 睿昂基因：10月10日获融资买入217.63万元
2025-10-11 - 睿昂基因：10月9日获融资买入499.43万元
2025-10-10 - 睿昂基因：9月30日获融资买入182.18万元
2025-10-01 - 睿昂基因：9月29日获融资买入190.56万元
2025-09-30 - 睿昂基因：9月26日获融资买入158.68万元
2025-09-27 - 睿昂基因：9月25日获融资买入218.98万元
2025-09-26 - 睿昂基因：9月24日获融资买入322.62万元
2025-09-25 - 睿昂基因：9月23日获融资买入220.03万元
2025-09-24
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-10-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-24 |
| 一般消息 | 募资投向 | 2025-09-18 | |
| 一般消息 | 高管变动 | 个人原因 | 2025-09-08 |
| 利好 | 分红转增 | 10派1.7元(含税) | 2025-08-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-18 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-12-05 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-10-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：0.0行业面打败了11%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.10.15","price":"1.22","value":null},{"date":"2025.10.14","price":"-0.62","value":null},{"date":"2025.10.13","price":"-0.19","value":null},{"date":"2025.10.10","price":"-0.94","value":null},{"date":"2025.10.09","price":"1.32","value":null},{"date":"2025.09.30","price":"0.52","value":null},{"date":"2025.09.29","price":"0.90","value":null},{"date":"2025.09.26","price":"-0.65","value":null},{"date":"2025.09.25","price":"-0.01","value":null},{"date":"2025.09.24","price":"0.83","value":null},{"date":"2025.09.23","price":"-0.18","value":null},{"date":"2025.09.22","price":"0.22","value":null},{"date":"2025.09.19","price":"-0.30","value":null},{"date":"2025.09.18","price":"-1.15","value":null},{"date":"2025.09.17","price":"0.37","value":null},{"date":"2025.09.16","price":"0.04","value":null},{"date":"2025.09.15","price":"-0.26","value":null},{"date":"2025.09.12","price":"-0.12","value":null},{"date":"2025.09.11","price":"1.65","value":null},{"date":"2025.09.10","price":"0.13","value":null},{"date":"2025.09.09","price":"-0.51","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 振德医疗 | 118.28% | 38.98% | 5.9分 |
| 2 | 英科医疗 | 17.48% | 16.52% | 6.2分 |
| 3 | 硕世生物 | 15.79% | 9.28% | 5.9分 |
| 4 | 海泰新光 | 15.01% | 5.17% | 6.1分 |
| 5 | 楚天科技 | 14.65% | 6.70% | 5.5分 |
| 6 | 采纳股份 | 12.61% | -4.19% | 4.3分 |
| 8 | - | 10.59% | 7.08% | 分 |
| 10 | 浩欧博 | 9.11% | -3.65% | 4.9分 |
| 12 | 五洲医疗 | 8.66% | 11.68% | 5.2分 |
| 14 | 透景生命 | 6.91% | 9.63% | 5.6分 |
| 16 | 麦克奥迪 | 6.78% | -1.46% | 5.7分 |
| 18 | 东富龙 | 3.43% | 3.79% | 6.1分 |
| 20 | 新华医疗 | 2.81% | 5.05% | 6.2分 |
| 22 | 天臣医疗 | 2.56% | -5.04% | 5.6分 |
| 24 | 奕瑞科技 | 1.61% | -1.22% | 6.0分 |
| 26 | 惠泰医疗 | 0.93% | -1.73% | 6.2分 |
| 28 | 赛诺医疗 | 0.80% | 6.89% | 6.0分 |
| 30 | 黄山胶囊 | 0.26% | 0.92% | 5.9分 |
| 32 | 大博医疗 | -0.38% | -0.86% | 5.7分 |
| 34 | 奥泰生物 | -0.58% | -1.16% | 6.0分 |
| 36 | 西山科技 | -0.76% | 1.54% | 5.3分 |
| 38 | 华大智造 | -1.34% | -0.87% | 4.8分 |
| 40 | 达安基因 | -1.53% | 0.94% | 5.9分 |
| 42 | 港通医疗 | -1.75% | -1.07% | 5.0分 |
| 44 | 爱威科技 | -1.90% | -0.54% | 6.1分 |
| 46 | 赛科希德 | -1.98% | -0.83% | 5.5分 |
| 48 | 海利生物 | -2.10% | 2.94% | 5.7分 |
| 50 | 博拓生物 | -2.40% | 2.09% | 4.9分 |
| 52 | 亚辉龙 | -2.47% | 0.55% | 5.7分 |
| 54 | 伟思医疗 | -2.71% | 0.54% | 5.9分 |
| 56 | 南微医学 | -2.82% | -8.78% | 6.1分 |
| 58 | 天益医疗 | -2.97% | -1.23% | 4.9分 |
| 60 | 康德莱 | -3.05% | 2.11% | 6.0分 |
| 62 | 仁度生物 | -3.07% | 1.59% | 5.2分 |
| 64 | 康泰医学 | -3.20% | -0.31% | 4.5分 |
| 66 | 威高血净 | -3.26% | 1.82% | 6.1分 |
| 68 | 山东药玻 | -3.35% | -0.65% | 5.3分 |
| 70 | 联影医疗 | -3.42% | -2.20% | 6.0分 |
| 72 | 心脉医疗 | -3.75% | -4.70% | 5.3分 |
| 74 | 三友医疗 | -3.81% | 0.15% | 5.7分 |
| 76 | 睿昂基因 | -3.85% | -2.07% | 5.3分 |
| 78 | 科华生物 | -4.15% | 1.09% | 5.5分 |
| 80 | 南卫股份 | -4.19% | 0.49% | 5.8分 |
| 82 | 迈瑞医疗 | -4.36% | -6.18% | 4.4分 |
| 84 | - | -4.45% | 8.73% | 分 |
| 86 | 万东医疗 | -4.55% | -2.73% | 5.7分 |
| 88 | 健尔康 | -4.68% | 0.57% | 5.5分 |
| 90 | 尚荣医疗 | -4.76% | 1.78% | 5.6分 |
| 92 | 乐心医疗 | -4.98% | -0.42% | 5.4分 |
| 94 | 阳普医疗 | -5.19% | 0.00% | 5.5分 |
| 96 | 康拓医疗 | -5.35% | -2.17% | 5.7分 |
| 98 | 迈克生物 | -5.46% | -0.26% | 5.0分 |
| 100 | 理邦仪器 | -5.54% | -1.09% | 5.5分 |
| 102 | 爱朋医疗 | -5.82% | -0.58% | 4.9分 |
| 104 | 山外山 | -6.07% | 1.56% | 6.1分 |
| 106 | 东方生物 | -6.40% | -1.51% | 5.0分 |
| 108 | 易瑞生物 | -6.56% | -2.75% | 4.7分 |
| 110 | 翔宇医疗 | -6.59% | 0.92% | 5.8分 |
| 112 | 三诺生物 | -6.81% | -1.05% | 4.9分 |
| 114 | 昊海生科 | -6.90% | -1.06% | 5.8分 |
| 116 | 奥精医疗 | -7.75% | -8.20% | 4.5分 |
| 118 | 力诺药包 | -8.24% | -1.69% | 4.5分 |
| 120 | 瑞迈特 | -8.45% | -0.46% | 5.4分 |
| 122 | 威高骨科 | -9.66% | -6.72% | 5.6分 |
| 124 | 安杰思 | -9.77% | -8.08% | 5.3分 |
| 126 | 新产业 | -10.11% | -8.32% | 4.4分 |
| 128 | - | -10.51% | -0.80% | 分 |
| 130 | 康众医疗 | -12.49% | -3.82% | 4.8分 |
| 132 | - | -14.17% | 1.80% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 94/247 ， 18/247。
[{"date":"2025-06-30","value":"0.39","vol":"2.27"},{"date":"2025-03-31","value":"0.37","vol":"1.15"},{"date":"2024-12-31","value":"-1.70","vol":"0.53"},{"date":"2024-09-30","value":"0.61","vol":"4.75"},{"date":"2024-06-30","value":"0.98","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.39 | 0.37 | -1.70 | 0.61 | 0.98 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"72.98","vol":"52.10"},{"date":"2025-03-31","value":"71.00","vol":"51.81"},{"date":"2024-12-31","value":"74.53","vol":"52.63"},{"date":"2024-09-30","value":"76.08","vol":"53.58"},{"date":"2024-06-30","value":"75.11","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
72.98 | 71.00 | 74.53 | 76.08 | 75.11 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 110/247 ， 100/247。
[{"date":"2025-06-30","value":"-22.29","vol":"-1.71"},{"date":"2025-03-31","value":"-14.72","vol":"-0.92"},{"date":"2024-12-31","value":"-6.16","vol":"0.64"},{"date":"2024-09-30","value":"-4.62","vol":"0.79"},{"date":"2024-06-30","value":"5.66","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-22.29 | -14.72 | -6.16 | -4.62 | 5.66 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-61.46","vol":"-20.27"},{"date":"2025-03-31","value":"529.26","vol":"-4.25"},{"date":"2024-12-31","value":"-298.78","vol":"-24.11"},{"date":"2024-09-30","value":"-69.58","vol":"-20.40"},{"date":"2024-06-30","value":"-43.20","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-61.46 | 529.26 | -298.78 | -69.58 | -43.20 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 96/247 ， 88/247。
[{"date":"2025-06-30","value":"0.11","vol":"0.17"},{"date":"2025-03-31","value":"0.06","vol":"0.08"},{"date":"2024-12-31","value":"0.24","vol":"0.35"},{"date":"2024-09-30","value":"0.18","vol":"0.26"},{"date":"2024-06-30","value":"0.13","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.06 | 0.24 | 0.18 | 0.13 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.70","vol":"1.13"},{"date":"2025-03-31","value":"0.36","vol":"0.55"},{"date":"2024-12-31","value":"1.19","vol":"2.33"},{"date":"2024-09-30","value":"0.81","vol":"1.67"},{"date":"2024-06-30","value":"0.59","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.70 | 0.36 | 1.19 | 0.81 | 0.59 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 78/247 ， 63/247。
[{"date":"2025-06-30","value":"13.89","vol":"15.06"},{"date":"2025-03-31","value":"19.25","vol":"4.01"},{"date":"2024-12-31","value":"51.98","vol":"29.58"},{"date":"2024-09-30","value":"37.03","vol":"15.37"},{"date":"2024-06-30","value":"1.09","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 13.89 | 19.25 | 51.98 | 37.03 | 1.09 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.15","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.84","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.31","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.15 | - | 0.84 | - | 0.31 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 124/247 ， 122/247。
[{"date":"2025-06-30","value":"15.02","vol":"5.50"},{"date":"2025-03-31","value":"10.68","vol":"5.89"},{"date":"2024-12-31","value":"12.14","vol":"5.34"},{"date":"2024-09-30","value":"12.42","vol":"5.97"},{"date":"2024-06-30","value":"11.60","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
15.02 | 10.68 | 12.14 | 12.42 | 11.60 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"13.09","vol":"4.40"},{"date":"2025-03-31","value":"9.08","vol":"4.77"},{"date":"2024-12-31","value":"10.48","vol":"4.32"},{"date":"2024-09-30","value":"10.60","vol":"4.82"},{"date":"2024-06-30","value":"9.95","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
13.09 | 9.08 | 10.48 | 10.60 | 9.95 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 127/247 ， 127/247。
[{"date":"2025-06-30","value":"4.26","vol":"22.01"},{"date":"2025-03-31","value":"5.59","vol":"21.24"},{"date":"2024-12-31","value":"6.60","vol":"21.92"},{"date":"2024-09-30","value":"6.59","vol":"21.09"},{"date":"2024-06-30","value":"7.00","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
4.26 | 5.59 | 6.60 | 6.59 | 7.00 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.04","vol":"0.58"},{"date":"2025-03-31","value":"0.06","vol":"0.57"},{"date":"2024-12-31","value":"0.07","vol":"0.55"},{"date":"2024-09-30","value":"0.07","vol":"0.38"},{"date":"2024-06-30","value":"0.08","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.04 | 0.06 | 0.07 | 0.07 | 0.08 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.47","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.08","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.16","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]